Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mutations01:39

Mutations

94.7K
Overview
94.7K
Translation01:31

Translation

157.5K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
157.5K
Translation01:31

Translation

18.2K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
18.2K
Mismatch Repair01:20

Mismatch Repair

6.7K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monocytosis in polycythemia vera: Clinical and molecular correlates.

American journal of hematology·2017
Same author

Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia.

American journal of hematology·2017
Same author

Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis.

The Journal of clinical investigation·2017
Same author

The prognostic relevance of serum lactate dehydrogenase and mild bone marrow reticulin fibrosis in essential thrombocythemia.

American journal of hematology·2017
Same author

Diagnostic impact of the 2016 revised who criteria for polycythemia vera.

American journal of hematology·2017
Same author

Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis (RARS-T): 2017 update on diagnosis, risk-stratification, and management.

American journal of hematology·2017

Related Experiment Video

Updated: Feb 16, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

25.1K

Driver mutations in primary myelofibrosis and their implications.

Natasha Szuber1, Ayalew Tefferi

  • 1Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Current Opinion in Hematology
|December 20, 2017
PubMed
Summary

Driver mutations in primary myelofibrosis (PMF) impact disease characteristics and outcomes. Understanding these genetic factors is crucial for refining treatment strategies and predicting patient prognosis in this myeloproliferative neoplasm.

More Related Videos

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
11:48

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

13.4K
Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
11:06

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

13.5K

Related Experiment Videos

Last Updated: Feb 16, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

25.1K
Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
11:48

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

13.4K
Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
11:06

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

13.5K

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Primary myelofibrosis (PMF) is a BCR-ABL1 negative myeloproliferative neoplasm.
  • Key driver mutations include Janus kinase 2 (JAK2), calreticulin (CALR), and myeloproliferative leukemia virus oncogene (MPLW).

Purpose of the Study:

  • To comprehensively review the phenotypic, therapeutic, and prognostic implications of driver mutations in PMF.
  • To explore how these mutations influence disease pathogenesis and clinical heterogeneity.

Main Methods:

  • Comprehensive literature review of studies on PMF driver mutations.
  • Analysis of existing data on genotype-phenotype and genotype-prognosis correlations.

Main Results:

  • Driver mutations are pathogenetically relevant and influence disease outcomes in PMF.
  • Advances in understanding CALR mutations and their impact.
  • Interactions between driver mutations and additional genetic alterations affect disease course.

Conclusions:

  • Phenotypic and prognostic correlates of driver mutations in PMF are supported by existing literature.
  • Further research into the functional impact and interactions of these mutations is needed.
  • Understanding the complex genetic landscape may alter clinical management of PMF.